Laboratory and clinical features of TMA
| Laboratory features | Microangiopathic hemolytic anemia |
| Anemia | |
| Fragmented red blood cells (schistocytes) | |
| Decreased haptoglobin | |
| Thrombocytopenia | |
| Evidence of end-organ damage/ischemia | |
| Elevated lactate dehydrogenase levels | |
| Clinical features | Evidence of end-organ damage/ischemia |
| Brain, neurologic dysfunction | |
| Kidneys, elevated creatinine/renal failure | |
| Fever |
| Laboratory features | Microangiopathic hemolytic anemia |
| Anemia | |
| Fragmented red blood cells (schistocytes) | |
| Decreased haptoglobin | |
| Thrombocytopenia | |
| Evidence of end-organ damage/ischemia | |
| Elevated lactate dehydrogenase levels | |
| Clinical features | Evidence of end-organ damage/ischemia |
| Brain, neurologic dysfunction | |
| Kidneys, elevated creatinine/renal failure | |
| Fever |